Genetic polymorphism at miR-181a binding site contributes to gastric cancer susceptibility

Carcinogenesis

Volumn 33, Issue 12, 2012, Pages 2377-2383

  Lin, Yong ^a   Nie, Yuqiang ^a   Zhao, Jing ^a   Chen, Xi ^a   Ye, Min ^a   Li, Yingfei ^a   Du, Yanlei ^a   Cao, Jie ^a   Shen, Bo ^a   Li, Yuyuan ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 181A; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BINDING SITE; BIOINFORMATICS; CANCER SUSCEPTIBILITY; CHINESE; ENZYME ANALYSIS; FEMALE; GENE EXPRESSION; GENE TARGETING; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER; UPREGULATION;

3' UNTRANSLATED REGIONS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BINDING SITES; CASE-CONTROL STUDIES; CELL LINE, TUMOR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN TYROSINE PHOSPHATASES, NON-RECEPTOR; REAL-TIME POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS;

EID: 84870328664     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs292     Document Type: Article

References (49)

1. Jemal, A. et al. (2011) Global cancer statistics. CA. Cancer J. Clin., 61, 69-90.
2. Brennecke, J. et al. (2005) Principles of microRNA-target recognition. PLoS Biol., 3, e85.
3. Brodersen, P. et al. (2009) Revisiting the principles of microRNA target recognition and mode of action. Nat. Rev. Mol. Cell Biol., 10, 141-148.
4. Chin, L.J. et al. (2008) A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk. Cancer Res., 68, 8535-8540.
5. Landi, D. et al. (2008) Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer. Carcinogenesis, 29, 579-584.
6. Zhang, L. et al. (2011) Functional SNP in the microRNA-367 binding site in the 3'UTR of the calcium channel ryanodine receptor gene 3 (RYR3) affects breast cancer risk and calcification. Proc. Natl. Acad. Sci. U.S.A., 108, 13653-13658.
7. Christensen, B.C. et al. (2009) A let-7 microRNA-binding site polymorphism in the KRAS 3' UTR is associated with reduced survival in oral cancers. Carcinogenesis, 30, 1003-1007.
8. Teo, M.T. et al. (2012) The role of microRNA-binding site polymorphisms in DNA repair genes as risk factors for bladder cancer and breast cancer and their impact on radiotherapy outcomes. Carcinogenesis, 33, 581-586.
9. Edge, S.B. et al. (2010) AJCC Cancer Staging Manual. 7th edn. Springer, New York, NY.
10. Sakamoto, H. et al. (2008) Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer. Nat. Genet., 40, 730-740.
11. Livak, K.J. et al. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 25, 402-408.
12. Lewis, B.P. et al. (2003) Prediction of mammalian microRNA targets. Cell, 115, 787-798.
13. Betel, D. et al. (2008) The microRNA.org resource: targets and expression. Nucleic Acids Res., 36, D149-153.
14. Kertesz, M. et al. (2007) The role of site accessibility in microRNA target recognition. Nat. Genet., 39, 1278-1284.
15. Krek, A. et al. (2005) Combinatorial microRNA target predictions. Nat. Genet., 37, 495-500.
16. Papadopoulos, G.L. et al. (2009) The database of experimentally supported targets: a functional update of TarBase. Nucleic Acids Res., 37, D155-158.
17. Xiao, F. et al. (2009) miRecords: an integrated resource for microRNAtarget interactions. Nucleic Acids Res., 37, D105-110.
18. Hsu, S.D. et al. (2011) miRTarBase: a database curates experimentally validated microRNA-target interactions. Nucleic Acids Res., 39, D163-169.
19. John, B. et al. (2004) Human MicroRNA targets. PLoS Biol., 2, e363.
20. Yang, Q. et al. (2011) Low-level expression of let-7a in gastric cancer and its involvement in tumorigenesis by targeting RAB40C. Carcinogenesis, 32, 713-722.
21. Berezikov, E. et al. (2006) Diversity of microRNAs in human and chimpanzee brain. Nat. Genet., 38, 1375-1377.
22. Kozomara, A. et al. (2011) miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res., 39, D152-157.
23. Jin, Z. et al. (2011) MicroRNA-192 and -215 are upregulated in human gastric cancer in vivo and suppress ALCAM expression in vitro. Oncogene, 30, 1577-1585.
24. Li, X. et al. (2010) Survival prediction of gastric cancer by a seven-micro-RNA signature. Gut, 59, 579-585.
25. Liu, T. et al. (2009) MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin. Cancer Lett., 273, 233-242.
26. Ueda, T. et al. (2010) Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol., 11, 136-146.
27. Yao, Y. et al. (2009) MicroRNA profiling of human gastric cancer. Mol. Med. Rep., 2, 963-970.
28. Ji, J. et al. (2009) Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells. Hepatology, 50, 472-480.
29. Ota, D. et al. (2011) Identification of recurrence-related microRNAs in the bone marrow of breast cancer patients. Int. J. Oncol., 38, 955-962.
30. Yang, C.C. et al. (2011) miR-181 as a putative biomarker for lymph-node metastasis of oral squamous cell carcinoma. J. Oral Pathol. Med., 40, 397-404.
31. Wang, Y. et al. (2011) Transforming growth factor-β regulates the sphereinitiating stem cell-like feature in breast cancer through miRNA-181 and ATM. Oncogene, 30, 1470-1480.
32. Meng, F. et al. (2012) Functional analysis of microRNAs in human hepatocellular cancer stem cells. J. Cell. Mol. Med., 16, 160-173.
33. Shin, K.H. et al. (2011) miR-181a shows tumor suppressive effect against oral squamous cell carcinoma cells by downregulating K-ras. Biochem. Biophys. Res. Commun., 404, 896-902.
34. Zhu, W. et al. (2010) miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines. Int. J. Cancer, 127, 2520-2529.
35. Pallasch, C.P. et al. (2009) miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia. Blood, 114, 3255-3264.
36. Gao, W. et al. (2010) MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis. J. Cancer Res. Clin., 137, 557-566.
37. Schwind, S. et al. (2010) Prognostic significance of expression of a single microRNA, miR-181a, in cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study. J. Clin. Oncol., 28, 5257-5264.
38. Ciafre, S.A. et al. (2005) Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem. Biophys. Res. Co., 334, 1351-1358.
39. Kim, C.H. et al. (2011) miRNA signature associated with outcome of gastric cancer patients following chemotherapy. BMC Med. Genomics, 4, 79.
40. Yao, Y. et al. (2009) MicroRNA profiling of human gastric cancer. Mol. Med. Rep., 2, 963-970.
41. Hashimoto, Y. et al. (2010) Involvement of epigenetically silenced micro-RNA-181c in gastric carcinogenesis. Carcinogenesis, 31, 777-784.
42. Dawidowicz, K. et al. (2011) The interferon regulatory factor 5 gene confers susceptibility to rheumatoid arthritis and influences its erosive phenotype. Ann. Rheum. Dis., 70, 117-121.
43. Sigurdsson, S. et al. (2008) Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus. Hum. Mol. Genet., 17, 872-881.
44. Yu, X.Q. et al. (2012) A genome-wide association study in Han Chinese identifies multiple susceptibility loci for IgA nephropathy. Nat. Genet., 44, 178-182.
45. Taguchi-Atarashi, N. et al. (2010) Modulation of local PtdIns3P levels by the PI phosphatase MTMR3 regulates constitutive autophagy. Traffic, 11, 468-478.
46. Walker, D.M. et al. (2001) Characterization of MTMR3. an inositol lipid 3-phosphatase with novel substrate specificity. Curr. Biol., 11, 1600-1605.
47. Mathew, R. et al. (2007) Role of autophagy in cancer. Nat. Rev. Cancer, 7, 961-967.
48. Imielinski, M. et al. (2009) Common variants at five new loci associated with early-onset inflammatory bowel disease. Nat. Genet., 41, 1335-1340.
49. Song, S.Y. et al. (2010) Mutational analysis of mononucleotide repeats in dual specificity tyrosine phosphatase genes in gastric and colon carcinomas with microsatellite instability. APMIS, 118, 389-393.